Global perspectives on MASCC clinical practice guidelines: awareness, implementation and insights to inform future updates
Supportive Care in Cancer · 2026-11 · 34 (11)
DOI: 10.1007/s00520-026-11388-1 ↗Kurz gefasst
Leitlinie in der Zeitschrift Supportive Care in Cancer, online erschienen am 04.11.2026. Verfasst von Ragda Abdalla-Aslan und 30 weiteren Autor:innen. Beteiligte Einrichtung: Technion Israel Institute of Technology, Faculty of Medicine, Technion City, Haifa, 3200003, Israel. ragdaa@technion.ac.il. Hauptthemen laut MEDLINE: Practice Guidelines as Topic, Neoplasms, Health Knowledge, Attitudes, Practice, Health Personnel. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Technion - Israel Institute of Technology.
Abstract (Originalsprache)
Purpose
The Multinational Association of Supportive Care in Cancer (MASCC) is internationally recognized for developing evidence-based Clinical Practice Guidelines (CPGs) for managing cancer or treatment–related toxicities, but their uptake remains uncertain. This study aimed to evaluate global awareness, utilization, and perceptions of MASCC CPGs, to inform strategies to enhance future updates and promote their implementation.
Methods
An international online survey was distributed via the MASCC platform between February and March 2025 to healthcare professionals specialized in supportive care in cancer. The survey included both closed- and open-ended questions addressing awareness, usage, perceived strengths and limitations, implementation challenges, and suggestions for improvement.
Results
A total of 423 responses were received, 264 (63%) from MASCC members. Participants represented all world regions, with 271 (65%) having 11–20 or more years of clinical experience. Overall, 302 (78%) reported routinely using MASCC CPGs in the management of cancer or treatment-related toxicities. Even among non-members, MASCC CPGs were cited as the most frequently used guidelines compared with other sources. The mucositis and antiemetics CPGs were the most recognized and applied. Key facilitators included the guidelines’ strong evidence and multidisciplinary development. Reported barriers included limited availability or high cost of recommended interventions. Respondents suggested improvements related to the timing of updates, dissemination strategies, and the inclusion of patient-facing guidelines.
Conclusions
MASCC CPGs are widely recognized and valued globally, yet implementation remains variable. Targeted efforts to address resource constraints and enhance dissemination may strengthen their global awareness and implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Technion Israel Institute of Technology, Faculty of Medicine, Technion City, Haifa, 3200003, Israel. ragdaa@technion.ac.il.
- Department of Oral and Maxillofacial Surgery, Rambam Health Care Campus, Haifa, Israel. ragdaa@technion.ac.il.
- School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
- Department of Hematology, Radboud University Medical Centre, Nijmegen, The Netherlands.
- Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
- School of Pharmacy and Biomedical Science, Adelaide University, Adelaide, Australia.
Förderung
- Technion - Israel Institute of Technology
Zitieren
APA
Abdalla-Aslan, R., Alberti, P., Blijlevens, N., Bonomo, P., Bowen, J., Bruno, J. S., Chan, R. J., Cheung, Y. T., Davies, A., Davis, M., Elad, S., Epstein, J., Fernandes, D., Freedman, J. L., Hart, N. H., Iihara, H., Jefford, M., Johnstone, D. P., Kleckner, A. S., …, & Bossi, P. (2026). Global perspectives on MASCC clinical practice guidelines: awareness, implementation and insights to inform future updates. Supportive Care in Cancer, 34(11). https://doi.org/10.1007/s00520-026-11388-1
Vancouver
Abdalla-Aslan R, Alberti P, Blijlevens N, Bonomo P, Bowen J, Bruno JS, et al. Global perspectives on MASCC clinical practice guidelines: awareness, implementation and insights to inform future updates. Supportive Care in Cancer. 2026;34(11). doi:10.1007/s00520-026-11388-1
BibTeX
@article{AbdallaAslan2026,
author = {Abdalla-Aslan, Ragda and Alberti, Paola and Blijlevens, Nicole and Bonomo, Pierluigi and Bowen, Joanne and Bruno, Julia S and Chan, Raymond J and Cheung, Yin Ting and Davies, Andrew and Davis, Mellar and Elad, Sharon and Epstein, Joel and Fernandes, Darren and Freedman, Jason L and Hart, Nicolas H and Iihara, Hirotoshi and Jefford, Michael and Johnstone, Daniel Peter and Kleckner, Amber S and Koczwara, Bogda and Kotronoulas, Grigorios and Munro, Emma and Murphy, Barbara and Nakagaki, Midori and Soto-Perez-de-Celis, Enrique and Sonis, Stephen and Tsoukalas, Nikolaos and Ugalde, Anna and van den Hurk, Corina and Wardill, Hannah Rose and Bossi, Paolo},
title = {Global perspectives on MASCC clinical practice guidelines: awareness, implementation and insights to inform future updates},
journal = {Supportive Care in Cancer},
year = {2026},
volume = {34},
number = {11},
doi = {10.1007/s00520-026-11388-1}
}
EUVIMED